What To Watch In Pay-For-Delay Trial Against Merck, Glenmark
By Cara Salvatore · April 17, 2023, 7:22 PM EDT
Merck and generic-drug maker Glenmark are set to start a trial this week on claims that they gouged buyers of Merck's blockbuster cholesterol drug Zetia by forging a pay-for-delay deal....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login